Literature DB >> 27402452

Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.

R Paul Wadwa1, H Peter Chase1, Dan Raghinaru2, Bruce A Buckingham3, Irene Hramiak4, David M Maahs1, Laurel Messer1, Trang Ly3, Tandy Aye3, Paula Clinton3, Craig Kollman2, Roy W Beck2, John Lum2.   

Abstract

OBJECTIVE: To compare the frequency of elevated morning blood ketone levels according to age in 4-14 year olds with type 1 diabetes following overnight use of an automated low glucose insulin suspension system, or following control nights when the system was not used. RESEARCH DESIGN AND METHODS: For 28 children ages 4-9 years and 54 youth ages 10-14 years, elevation of morning blood ketone levels was assessed using the Precision Xtra Ketone meter following 1155 and 2345 nights, respectively. Repeated measures logistic regression models were used to compare age groups for blood ketone level elevation following control nights (system not activated) and following intervention nights with and without insulin suspension.
RESULTS: Elevated morning blood ketones (≥0.6 mmol/L) were present following 10% of 580 control nights in the 4-9 year olds compared with 2% of 1162 control nights in 10-14 year olds (P < 0.001). Likewise, the frequency was greater following intervention nights in the younger age group (13% of 575 nights vs 2% of 1183 nights, P < 0.001). A longer duration of pump suspension resulted in a higher percentage of mornings with elevated blood ketones in the younger age group (P = 0.002), but not in the older age group (P = 0.63). The presence of elevated morning ketone levels did not progress to ketoacidosis in any subject.
CONCLUSIONS: Elevated morning blood ketones are more common in younger children with type 1 diabetes with or without nocturnal insulin suspension. Care providers need to be aware of the differences in ketogenesis in younger age children relative to various clinical situations.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  insulin pump; ketosis; pediatric; type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27402452      PMCID: PMC5233607          DOI: 10.1111/pedi.12410

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  16 in total

1.  Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

Authors:  N Attia; T W Jones; J Holcombe; W V Tamborlane
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

2.  The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level.

Authors:  M J Castillo; A J Scheen; P J Lefèbvre
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

3.  Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose.

Authors:  D M Bier; R D Leake; M W Haymond; K J Arnold; L D Gruenke; M A Sperling; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

4.  Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients.

Authors:  Bruno Guerci; Muriel Benichou; Michèle Floriot; Philip Bohme; Sebastien Fougnot; Patricia Franck; Pierre Drouin
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

5.  Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.

Authors:  Eva Tsalikian; Craig Kollman; William B Tamborlane; Roy W Beck; Rosanna Fiallo-Scharer; Larry Fox; Kathleen F Janz; Katrina J Ruedy; Darrell Wilson; Dongyuan Xing; Stuart A Weinzimer
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

6.  Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes.

Authors:  M Orsini-Federici; J Akwe Akwi; V Canonico; R Celleno; P Ferolla; R Pippi; C Tassi; A Timi; M Massi Benedetti
Journal:  Diabetes Technol Ther       Date:  2006-02       Impact factor: 6.118

7.  A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control.

Authors:  G Krzentowski; A Scheen; M Castillo; A S Luyckx; P J Lefèbvre
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

8.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Authors:  Bruce A Buckingham; Dan Raghinaru; Fraser Cameron; B Wayne Bequette; H Peter Chase; David M Maahs; Robert Slover; R Paul Wadwa; Darrell M Wilson; Trang Ly; Tandy Aye; Irene Hramiak; Cheril Clarson; Robert Stein; Patricia H Gallego; John Lum; Judy Sibayan; Craig Kollman; Roy W Beck
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

9.  Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system.

Authors:  Roy W Beck; Dan Raghinaru; R Paul Wadwa; H Peter Chase; David M Maahs; Bruce A Buckingham
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

10.  A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.

Authors:  David M Maahs; Peter Calhoun; Bruce A Buckingham; H Peter Chase; Irene Hramiak; John Lum; Fraser Cameron; B Wayne Bequette; Tandy Aye; Terri Paul; Robert Slover; R Paul Wadwa; Darrell M Wilson; Craig Kollman; Roy W Beck
Journal:  Diabetes Care       Date:  2014-05-07       Impact factor: 19.112

View more
  3 in total

1.  Plasma β-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department.

Authors:  Elise Schlissel Tremblay; Kate Millington; Michael C Monuteaux; Richard G Bachur; Joseph I Wolfsdorf
Journal:  Pediatr Emerg Care       Date:  2021-12-01       Impact factor: 1.454

2.  Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association.

Authors:  Jane L Chiang; David M Maahs; Katharine C Garvey; Korey K Hood; Lori M Laffel; Stuart A Weinzimer; Joseph I Wolfsdorf; Desmond Schatz
Journal:  Diabetes Care       Date:  2018-08-09       Impact factor: 19.112

Review 3.  Monitoring of Pediatric Type 1 Diabetes.

Authors:  Brynn E Marks; Joseph I Wolfsdorf
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-17       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.